ADAM15 and breast cancer: We show for the first time ADAM15 isoform-, and catalytic function-dependent upregulation of Claudin-1 expression, which may be responsible for the effects of ADAM15 on cancer cell phenotypes and prognostic outcomes for breast cancer patients.